974 related articles for article (PubMed ID: 26270045)
1. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
Song J; Su H; Zhou YY; Guo LL
Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis.
Miao C; Liang C; Zhu J; Xu A; Zhao K; Hua Y; Zhang J; Chen W; Suo C; Zhang C; Liu Y; Su S; Wang Z
Oncotarget; 2017 May; 8(19):32309-32321. PubMed ID: 28427222
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.
Jiang H; Li H
BMC Cancer; 2021 Feb; 21(1):149. PubMed ID: 33568081
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MMPs Functions as a Prognostic Biomarker for Oral Cancer Patients: A Systematic Review and Meta-analysis.
Deng W; Peng W; Wang T; Chen J; Zhu S
Oral Health Prev Dent; 2019; 17(6):505-514. PubMed ID: 31825023
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis.
Chen W; Huang S; Shi K; Yi L; Liu Y; Liu W
Cancer Control; 2021; 28():10732748211033743. PubMed ID: 34482737
[TBL] [Abstract][Full Text] [Related]
7. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
Chen Y; Wang X; Chen G; Dong C; Zhang D
PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.
Li HC; Cao DC; Liu Y; Hou YF; Wu J; Lu JS; Di GH; Liu G; Li FM; Ou ZL; Jie C; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2004 Nov; 88(1):75-85. PubMed ID: 15538048
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women.
Song N; Sung H; Choi JY; Han S; Jeon S; Song M; Lee Y; Park C; Park SK; Lee KM; Yoo KY; Noh DY; Ahn SH; Lee SA; Kang D
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1371-80. PubMed ID: 22634108
[TBL] [Abstract][Full Text] [Related]
13. Correlation between miR-200 Family Overexpression and Cancer Prognosis.
Liu W; Zhang K; Wei P; Hu Y; Peng Y; Fang X; He G; Wu L; Chao M; Wang J
Dis Markers; 2018; 2018():6071826. PubMed ID: 30069274
[TBL] [Abstract][Full Text] [Related]
14. Effects of coenzyme Q10 supplementation on inflammation, angiogenesis, and oxidative stress in breast cancer patients: a systematic review and meta-analysis of randomized controlled- trials.
Alimohammadi M; Rahimi A; Faramarzi F; Golpour M; Jafari-Shakib R; Alizadeh-Navaei R; Rafiei A
Inflammopharmacology; 2021 Jun; 29(3):579-593. PubMed ID: 34008150
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
Li CY; Yuan P; Lin SS; Song CF; Guan WY; Yuan L; Lai RB; Gao Y; Wang Y
Tumour Biol; 2013 Apr; 34(2):735-41. PubMed ID: 23269605
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis.
Chen J; Chen LJ; Zhou HC; Yang RB; Lu Y; Xia YL; Wu W; Hu LW
Hepatogastroenterology; 2014; 61(130):518-24. PubMed ID: 24901174
[TBL] [Abstract][Full Text] [Related]
17. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
Zhou S; Liu C; Wu SM; Wu RL
Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis.
Zhang QW; Liu L; Chen R; Wei YQ; Li P; Shi HS; Zhao YW
Asian Pac J Cancer Prev; 2012; 13(6):2903-8. PubMed ID: 22938481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
